Search Results - "Blanchard, Isabelle"

Phase II Trial of Regorafenib and Oral Methotrexate in Previously Treated Advanced KRAS-Mutant NSCLC by Aredo, Jacqueline V., Wakelee, Heather A., Ramchandran, Kavitha J., Neal, Joel W., Diehn, Maximilian, Hui, Angela Bik-Yu, Salahudeen, Ameen, Kwong, Bernice, Berry, Gerald J., Guo, H. Henry, Cunanan, Kristen, Vali, Shireen, Pancirer, Danny, Tsang, Vivian, Hwang, Grace, Loza, Monica, Johnson, Brittany, Blanchard, Isabelle, Padda, Sukhmani K.

“…There are no standard targeted treatment options for advanced KRAS-mutant NSCLC beyond KRAS G12C inhibitors. A computational model identified regorafenib and…”
Get full text

Molecular Characteristics and Pretreatment Neutrophil-to-Lymphocyte Ratio as Predictors of Durable Clinical Benefit from Immune Checkpoint Inhibition in Non-Small Cell Lung Cancer by Shah, Arpeet T., Blanchard, Isabelle, Padda, Sukhmani K., Wakelee, Heather A., Neal, Joel W.

“…This study explored the predictive potential of molecular characteristics and pretreatment Neutrophil-to-Lymphocyte Ratio (NLR) for in non-small cell lung…”
Get full text

Adsorption of Polyisobutenylsuccinimide Derivatives at a Solid−Hydrocarbon Interface by Dubois-Clochard, M.-Cl, Durand, J.-P, Delfort, B, Gateau, P, Barré, L, Blanchard, I, Chevalier, Y, Gallo, R

“…The adsorption of polymer dispersants of the polyisobutenylsuccinimide series has been studied at the solid/xylene interface. Carbon black was studied as a…”
Get full text

Chromatin immunoselection defines a TAL-1 target gene by Cohen-Kaminsky, Sylvia, Maouche-Chrétien, Leïla, Vitelli, Luigi, Vinit, Marie-Antoinette, Blanchard, Isabelle, Yamamoto, Masayugi, Peschle, Cesare, Roméo, Paul-Henri

“…Despite the major functions of the basic helix–loop–helix transcription factor TAL‐1 in hematopoiesis and T‐cell leukemogenesis, no TAL‐1 target gene has been…”
Get full text